ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sertraline → Sertraline, cis-(-)-

HRID 1290343
印刷

反応式

HRID 1290343 の反応式
[CH3:1][NH:2][C@@H:3]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[C@H:6]([C:13]2[CH:14]=[CH:15][C:16]([Cl:20])=[C:17]([Cl:19])[CH:18]=2)[CH2:5][CH2:4]1.ClC1C=C([C@H]2C3C(=CC=CC=3)C(=O)CC2)C=CC=1Cl>>[CH3:1][NH:2][C@H:3]1[C:8]2[C:7](=[CH:12][CH:11]=[CH:10][CH:9]=2)[C@@H:6]([C:13]2[CH:14]=[CH:15][C:16]([Cl:20])=[C:17]([Cl:19])[CH:18]=2)[CH2:5][CH2:4]1
参加物実験手順後処理出典と根拠反応ノート

参加物

3

反応物 2

HCID 68617SertralineHCID 1474501Sertraline ketone2 回

生成物 1

HCID 54375Sertraline, cis-(-)-

実験手順

The (4S)-4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone final product afforded by the process of this invention is a valuable intermediate that can be used to synthesize the antidepressant agent known as sertraline or cis-(1S)(4S)-N-methyl4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine by methods disclosed in the previously discussed prior art. More specifically, (4S)-4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone is first converted to (4S)-N-[4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidine]methanamine and then finally to the desired cis-(1S)(4S)-N-methyl4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine by the known methods of the prior art process, as earlier described in U.S. Pat. No. 4,536,518 (Aug. 20, 1985). In the present instance, the optically-active ketone, viz., (4S)-4-(3,4-dichlorophenyl)-1(2H)-naphthalenone, is first reductively aminated to give chiral cis-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine and the latter product is then separated by chromatographic means to ultimately yield the desired final medicinal product which is sertraline.

後処理

  1. customto synthesize the antidepressant agent

出典と根拠

ORDレコード
ord-56f6461c6f344fddbfc1774373317cad
出典データセット
uspto-grants-1998_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05750794

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート